Newsroom

Sorted by: Latest

-

Dynex Capital, Inc. Announces First Quarter 2026 Results

GLEN ALLEN, Va.--(BUSINESS WIRE)--Dynex Capital, Inc. (the "Company") (NYSE: DX), a REIT with a long track record of generating dividends from high-quality mortgage assets, reported its first quarter financial results today. Management will host a call today at 10:00 a.m. Eastern Time to discuss the results and business outlook. Details to access the call can be found below under "Earnings Conference Call." Financial Performance Summary and Other Highlights Total economic return of $(0.34) per...
-

First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Europe Rising Dividend Achievers UCITS ETF 17.04.2026 EDVY.LN IE000CPG9HG3 50,002.00 EUR 1,075,013.69 21.499  ...
-

First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust FactorFX UCITS ETF 17.04.2026 FXGB LN IE00BD5HBR05 37,992.00 GBP 765,304.38 27.336  ...
-

KBRA Releases Research – European CLO Manager Style Comparisons: April 2026 Update

LONDON--(BUSINESS WIRE)--KBRA releases a report that compares collateralised loan obligation (CLO) manager styles or approaches to investing in leveraged loan pools. As part of KBRA’s series on European CLO manager styles, this report follows our September 2025 update, highlighting key changes since that publication and focusing on the differences between CLO managers when evaluated across selected cross-metrics. While the governing classifications are Opportunistic and Conservative, these are...
-

First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust US Equity Income UCITS ETF 17.04.2026 UNCU.LN IE00BD6GCF16 801,374.00 USD 36,541,534.92 45.599  ...
-

Bill Nye ‘The Science Guy’ Joins Arbor Day Foundation Podcast In Latest Episode

LINCOLN, Neb.--(BUSINESS WIRE)--Iconic science educator Bill Nye joins the Arbor Day Foundation in the fourth episode of its new podcast, “Unearthing Optimism.” In a conversation with CEO and host Dan Lambe, Nye shares his journey to becoming the host of a beloved children’s science show, his passion for space exploration, and why the next generation gives him hope for the future. “You can’t help but smile when you listen to Bill. He has an irresistible energy and humor that multiple generation...
-

TTP Group Announces the Sale of LEX Diagnostics

CAMBRIDGE, England--(BUSINESS WIRE)--TTP today announced the acquisition by QuidelOrtho Corporation (Nasdaq: QDEL), a global leader in in vitro diagnostics, of LEX Diagnostics Limited, a UK-based molecular diagnostics company and a spin-out of TTP Group. Founded in 2020, LEX Diagnostics originated from a TTP innovation programme to translate a breakthrough in ultra-fast thermal control into a commercially viable diagnostic solution. This work led to the development of a point-of-care molecular...
-

First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust FactorFX UCITS ETF 17.04.2026 FTFX IE00BD5HBQ97 63,402.00 USD 1,691,312.27 26.676  ...
-

First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Bloomberg Nuclear Power UCITS ETF 17.04.2026 RCTR.LN IE000J5PESP7 150,002.00 USD 3,061,961.06 20.413  ...
-

Simulations Plus Expands Global Access to Model-Informed Drug Development Training Through Its 2026 Spring School

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Simulations Plus, Inc. (Nasdaq: SLP) (“Simulations Plus” or the “Company”), a global leader in model-informed and AI-accelerated drug development that advances biopharma innovation, today announced the successful completion of its 2026 Spring School, a global training initiative designed to expand access to model-informed drug development (MIDD) and strengthen the scientific foundation of the industry’s future workforce. More than 1,400 scientists...